相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global estimates of cancer prevalence for 27 sites in the adult population in 2008
Freddie Bray et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Environmental, lifestyle, and familial/ethnic factors associated with myeloproliferative neoplasms
Lesley A. Anderson et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Guideline for the diagnosis and management of myelofibrosis
John T. Reilly et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Incidence, survival and prevalence of myeloid malignancies in Europe
O. Visser et al.
EUROPEAN JOURNAL OF CANCER (2012)
Improving Survival Trends in Primary Myelofibrosis: An International Study
Francisco Cervantes et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Myeloproliferative disorders in older people
Wendy Osborne et al.
REVIEWS IN CLINICAL GERONTOLOGY (2012)
Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network
A. Smith et al.
BRITISH JOURNAL OF CANCER (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms
Magnus Bjorkholm et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Childhood Leukemia Incidence in Brazil According to Different Geographical Regions
Rejane de Souza Reis et al.
PEDIATRIC BLOOD & CANCER (2011)
Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms
Stephen T. Oh et al.
BLOOD (2010)
Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project
Milena Sant et al.
BLOOD (2010)
Guideline for investigation and management of adults and children presenting with a thrombocytosis
Claire N. Harrison et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Genetic Analysis of Transforming Events That Convert Chronic Myeloproliferative Neoplasms to Leukemias
Omar Abdel-Wahab et al.
CANCER RESEARCH (2010)
Incidence of polycythemia vera in a defined population
Stig Berglund et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Classification and diagnosis of myeloproliferative neoplasms according to the 2008 World Health Organization criteria
Martha Wadleigh et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
A. Tefferi
LEUKEMIA (2010)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
Significant increase in the apparent incidence of essential thrombocythemia related to new WHO diagnostic criteria: a population-based study
Francois Girodon et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany
M. Rohrbacher et al.
LEUKEMIA (2009)
Haematological malignancies: Incidence in Basse-Normandie, France, for 1997-2004
X. Troussard et al.
REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE (2009)
Prevalence of polycythemia vera and essential thrombocythemia
Xiaomei Ma et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs
Dana E. Rollison et al.
BLOOD (2008)
Cancer registration in developing countries: luxury or necessity?
Maria Grazia Valsecchi et al.
LANCET ONCOLOGY (2008)
Most pediatric patients with essential thrombocythemia show hypersensitivity to erythropoietin in vitro, with rare JAK2 V617F-positive erythroid colonies
Jitka Veselovska et al.
LEUKEMIA RESEARCH (2008)
The history of myeloproliferative disorders: before and after Dameshek
A. Tefferi
LEUKEMIA (2008)
Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms
A. Tefferi et al.
LEUKEMIA (2008)
Meta analysis: cancer risk in Barrett's oesophagus
T. Thomas et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis
T. Thomas et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
The burden of fatigue and quality of life in myeloproliferative disorders (MPDs) - An international internet-based survey of 1179 MPD patients
Ruben A. Mesa et al.
CANCER (2007)
Amendment to the guideline for diagnosis and investigation of polycythaemia/erythrocytosis
Mary F. McMullin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia
Andrew I. Schafer
BLOOD (2006)
Genetics of myeloid malignancies:: Pathogenetic and clinical implications
S Fröhling et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways
W Tong et al.
BLOOD (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)
Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study
G Finazzi et al.
BLOOD (2005)
Hematological malignancies in the Island of Sardinia, 1974-1993: Age and sex distributions and temporal changes in incidence
G Broccia et al.
HEMATOLOGICAL ONCOLOGY (2004)
Trends in the incidence of chronic Philadelphia chromosome negative (Ph-) myeloproliferative disorders in the city of Goteborg, Sweden, during 1983-99
P Johansson et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia
F Passamonti et al.
AMERICAN JOURNAL OF MEDICINE (2004)
The World Health Organization (WHO) classification of the myeloid neoplasms
JW Vardiman et al.
BLOOD (2002)
Incidence, clinical features and outcome of essential thrombocythaemia in a well defined geographical area
MK Jensen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2000)
分享论文
